Renal & Urology News spoke with two researchers who have been involved in studies of these agents: E. David Crawford, MD, and Tomasz M. Beer, MD.
Both urologists and nephrologists provide follow-up and continuity of care to patients after cancer nephrectomy.
Adjuvant treatments for RCC must be prioritized by physicians because ultimately value is determined by how medicine is practiced.
Medicine is making progress to refine patient care.
Medical research inherently seeks to improve approaches to clinical care.
Recent studies have cast doubt on the universal superiority of the conventional approach to dialysis.
Randomized clinical trials are often considered the highest level on which medical care should be based.
As the rate of acceleration in ESRD incidence decline, physicians should expect heightened battles for the ESRD fountains.
Patients diagnosed with prostate cancer often struggle with their diagnosis.
Renal & Urology News interviewed Matthew R. Weir, MD, director of the division of nephrology and professor of medicine at the University of Maryland School of Medicine in Baltimore.
If ESRD patients face increasing difficulty getting a kidney transplant in coming years, they may see an artificial kidney as the next best alternative.
Additional novel medical therapies to treat prostate cancer and earlier use of the existing medical therapies are the future of prostate cancer management.
Advances in prostate cancer screening, management and therapeutics have vastly improved patient care.
Renal and Urology News Articles
Sign Up for Free e-newsletters
NEPHROLOGY & UROLOGY NEWS
- Acute Kidney Injury (AKI)
- Chronic Kidney Disease (CKD)
- Contrast Nephropathy
- Cardiovascular Disease (CVD)
- Diabetic Nephropathy
- End-stage Renal Disease (ESRD)
- Lupus Nephritis
- Peritoneal Dialysis
- Secondary Hyperparathyroidism (SHPT)